Editorial Methodology.

AI-assisted research and drafting.

Wolverine articles use AI-assisted research and drafting. A human editor reviews every article before publish. We label articles where an AI clinical reviewer or named clinical advisor contributed (none in this launch batch).

Full pipeline disclosure (planner → retriever → dialectic → drafter → fact-checker → guardrails-linter → geo-shaper) will be added when the production pipeline ships in Phase 4.

What we don't do.

Wolverine content stays in the science-journalism lane as defined by FDCA §201(g)(1). We do not:

• Make clinical recommendations about peptide use.
• Provide dosing guidance, protocols, or personalised advice.
• Operate a symptom checker or intake questionnaire.
• Prescribe, dispense, or facilitate access to any substance.
• Represent that any substance diagnoses, cures, mitigates, or prevents any condition.

When a named clinical advisor is in place (Phase 8), articles will carry per-article advisory bylines and the editorial lane widens accordingly. That upgrade is non-breaking by design — it is a metadata change, not a structural one.

Citations and sources.

Every article cites primary sources — peer-reviewed studies, regulatory filings, official trial registries. Citing secondary sources requires tracing back to the primary. We apply strict fair-use discipline: every cited excerpt is ≤50 words. We do not republish content wholesale. Every article carries a structured Sources block at the foot.

See Editorial Standards for the full attribution policy, source-tier hierarchy, and lane-discipline rules.

Corrections.

Material errors are corrected promptly. Corrections appear as a visible notice at the top of the affected article. We do not silently edit published content. All historical versions are preserved in version control; the public article always shows the latest reviewed version.

See the corrections section of Editorial Standards for the full policy.